{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:13:35Z","timestamp":1793726015433,"version":"4.6.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,2,7]],"date-time":"2019-02-07T00:00:00Z","timestamp":1549497600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["817705193"],"award-info":[{"award-number":["817705193"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81501034"],"award-info":[{"award-number":["81501034"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s00228-019-02642-z","type":"journal-article","created":{"date-parts":[[2019,2,7]],"date-time":"2019-02-07T05:45:26Z","timestamp":1549518326000},"page":"795-800","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["IL-2 gene polymorphisms affect tacrolimus response in myasthenia gravis"],"prefix":"10.1007","volume":"75","author":[{"given":"Yang","family":"Shumei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Huanyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhibin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Wanlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Liqun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1523-0338","authenticated-orcid":false,"given":"Yang","family":"Huan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,7]]},"reference":[{"key":"2642_CR1","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/1471-2377-10-46","volume":"10","author":"AS Carr","year":"2010","unstructured":"Carr AS, Cardwell CR, McCarron PO, McConville J (2010) A systematic review of population based epidemiological studies in Myasthenia Gravis. BMC Neurol 10:46","journal-title":"BMC Neurol"},{"issue":"12","key":"2642_CR2","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1111\/j.1468-1331.2010.03089.x","volume":"17","author":"JB Andersen","year":"2010","unstructured":"Andersen JB, Engeland A, Owe JF, Gilhus NE (2010) Myasthenia gravis requiring pyridostigmine treatment in a national population cohort. Eur J Neurol 17(12):1445\u20131450","journal-title":"Eur J Neurol"},{"issue":"2","key":"2642_CR3","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1212\/WNL.0b013e3181ad53c2","volume":"73","author":"AT Heldal","year":"2009","unstructured":"Heldal AT, Owe JF, Gilhus NE, Romi F (2009) Seropositive myasthenia gravis: a nationwide epidemiologic study. Neurology 73(2):150\u2013151","journal-title":"Neurology"},{"issue":"4","key":"2642_CR4","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1212\/WNL.0000000000002790","volume":"87","author":"DB Sanders","year":"2016","unstructured":"Sanders DB, Wolfe GI, Benatar M, Evoli A, Gilhus NE, Illa I, Kuntz N, Massey JM, Melms A, Murai H, Nicolle M, Palace J, Richman DP, Verschuuren J, Narayanaswami P (2016) International consensus guidance for management of myasthenia gravis: executive summary. Neurology 87(4):419\u2013425","journal-title":"Neurology"},{"issue":"9","key":"2642_CR5","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1136\/jnnp-2011-300148","volume":"82","author":"H Yoshikawa","year":"2011","unstructured":"Yoshikawa H, Kiuchi T, Saida T, Takamori M (2011) Randomised, double-blind, placebo-controlled study of tacrolimus in myasthenia gravis. J Neurol Neurosurg Psychiatry 82(9):970\u2013977","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"8","key":"2642_CR6","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1111\/ene.13652","volume":"25","author":"D Chen","year":"2018","unstructured":"Chen D, Hou S, Zhao M, Sun X, Zhang H, Yang L (2018) Dose optimization of tacrolimus with therapeutic drug monitoring and CYP3A5 polymorphism in patients with myasthenia gravis. Eur J Neurol 25(8):1049\u20131049e80. https:\/\/doi.org\/10.1111\/ene.13652","journal-title":"Eur J Neurol"},{"issue":"2","key":"2642_CR7","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1111\/ene.13189","volume":"24","author":"T Kanai","year":"2017","unstructured":"Kanai T, Uzawa A, Kawaguchi N, Himuro K, Oda F, Ozawa Y, Kuwabara S (2017) Adequate tacrolimus concentration for myasthenia gravis treatment. Eur J Neurol 24(2):270\u2013275","journal-title":"Eur J Neurol"},{"issue":"42","key":"2642_CR8","doi-asserted-by":"crossref","first-page":"26431","DOI":"10.1016\/S0021-9258(18)47212-2","volume":"269","author":"NA Clipstone","year":"1994","unstructured":"Clipstone NA, Fiorentino DF, Crabtree GR (1994) Molecular analysis of the interaction of calcineurin with drug-immunophilin complexes. J Biol Chem 269(42):26431\u201326437","journal-title":"J Biol Chem"},{"issue":"3","key":"2642_CR9","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.1128\/MCB.19.3.2300","volume":"19","author":"CW Chow","year":"1999","unstructured":"Chow CW, Rinc\u00f3n M, Davis RJ (1999) Requirement for transcription factor NFAT in interleukin-2 expression. Mol Cell Biol 19(3):2300\u20132307","journal-title":"Mol Cell Biol"},{"issue":"2 Suppl","key":"2642_CR10","doi-asserted-by":"publisher","first-page":"25S","DOI":"10.1016\/j.transproceed.2004.01.018","volume":"36","author":"MH Kapturczak","year":"2004","unstructured":"Kapturczak MH, Meier-Kriesche HU, Kaplan B (2004) Pharmacology of calcineurin antagonists. Transplant Proc 36(2 Suppl):25S\u201332S. https:\/\/doi.org\/10.1016\/j.transproceed.2004.01.018","journal-title":"Transplant Proc"},{"issue":"1\u20132","key":"2642_CR11","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.jneuroim.2003.12.001","volume":"148","author":"F Matesanz","year":"2004","unstructured":"Matesanz F, Fedetz M, Leyva L, Delgado C, Fern\u00e1ndez O, Alcina A (2004) Effects of the multiple sclerosis associated -330 promoter polymorphism in IL2 allelic expression. J Neuroimmunol 148(1\u20132):212\u2013217. https:\/\/doi.org\/10.1016\/j.jneuroim.2003.12.001","journal-title":"J Neuroimmunol"},{"issue":"1","key":"2642_CR12","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/tan.12471","volume":"85","author":"J Zhou","year":"2015","unstructured":"Zhou J, Wang L, Wang F, Xu P, Li Y, Bai B, Dang L, Sun D (2015) 4q27 as a psoriasis susceptibility locus in the Northeastern Chinese Han population. Tissue Antigens 85(1):15\u201319. https:\/\/doi.org\/10.1111\/tan.12471","journal-title":"Tissue Antigens"},{"issue":"3","key":"2642_CR13","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1159\/000464381","volume":"41","author":"X Zhang","year":"2017","unstructured":"Zhang X, Lin S, Yang Y, Rong L, He G, He H, Xue Y, Fang Y, Wang Y (2017) Interleukin-2 and Interleukin-8 gene polymorphisms and acquired aplastic anemia risk in a Chinese population. Cell Physiol Biochem 41(3):1199\u20131207. https:\/\/doi.org\/10.1159\/000464381","journal-title":"Cell Physiol Biochem"},{"issue":"1","key":"2642_CR14","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/S0003-4975(00)01595-2","volume":"70","author":"A Jaretzki","year":"2000","unstructured":"Jaretzki A et al (2000) Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America. Ann Thorac Surg 70(1):327\u2013334","journal-title":"Ann Thorac Surg"},{"key":"2642_CR15","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1196\/annals.1405.000","volume":"1132","author":"JM Ponseti","year":"2008","unstructured":"Ponseti JM, Gamez J, Azem J, L\u00f3pez-Cano M, Vilallonga R, Armengol M (2008) Tacrolimus for myasthenia gravis: a clinical study of 212 patients. Ann N Y Acad Sci 1132:254\u2013263. https:\/\/doi.org\/10.1196\/annals.1405.000","journal-title":"Ann N Y Acad Sci"},{"issue":"5","key":"2642_CR16","doi-asserted-by":"publisher","first-page":"495","DOI":"10.2217\/pgs-2017-0182","volume":"19","author":"HY Meng","year":"2018","unstructured":"Meng HY, Luo ZH, Hu B, Jin WL, Yan CK, Li ZB, Xue YY, Liu Y, Luo YE, Xu LQ, Yang H (2018) SNPs affecting the clinical outcomes of regularly used immunosuppressants. Pharmacogenomics 19(5):495\u2013511. https:\/\/doi.org\/10.2217\/pgs-2017-0182","journal-title":"Pharmacogenomics"},{"issue":"5","key":"2642_CR17","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/75452","volume":"18","author":"R Favis","year":"2000","unstructured":"Favis R, Day JP, Gerry NP, Phelan C, Narod S, Barany F (2000) Universal DNA array detection of small insertions and deletions in BRCA1 and BRCA2. Nat Biotechnol 18(5):561\u2013564. https:\/\/doi.org\/10.1038\/75452","journal-title":"Nat Biotechnol"},{"issue":"3","key":"2642_CR18","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.hepres.2005.12.007","volume":"34","author":"Z Xiao","year":"2006","unstructured":"Xiao Z, Xiao J, Jiang Y, Zhang S, Yu M, Zhao J, Wei D, Cao H (2006) A novel method based on ligase detection reaction for low abundant YIDD mutants detection in hepatitis B virus. Hepatol Res 34(3):150\u2013155. https:\/\/doi.org\/10.1016\/j.hepres.2005.12.007","journal-title":"Hepatol Res"},{"issue":"4","key":"2642_CR19","doi-asserted-by":"publisher","first-page":"2776","DOI":"10.1007\/s12035-016-9865-7","volume":"54","author":"Z Zhang","year":"2017","unstructured":"Zhang Z, Xu G, Cai B, Zhang H, Zhu W, Liu X (2017) Genetic variants in microRNAs predict recurrence of ischemic stroke. Mol Neurobiol 54(4):2776\u20132780","journal-title":"Mol Neurobiol"},{"issue":"2","key":"2642_CR20","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1093\/bioinformatics\/bth457","volume":"21","author":"JC Barrett","year":"2005","unstructured":"Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21(2):263\u2013265","journal-title":"Bioinformatics"},{"key":"2642_CR21","doi-asserted-by":"publisher","unstructured":"Tron C, Lemaitre F, Verstuyft C, Petitcollin A, Verdier MC, Bellissant E (2018) Pharmacogenetics of membrane transporters of tacrolimus in solid organ transplantation. Clin Pharmacokinet. https:\/\/doi.org\/10.1007\/s40262-018-0717-7","DOI":"10.1007\/s40262-018-0717-7"},{"issue":"3","key":"2642_CR22","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.berh.2017.09.010","volume":"31","author":"CC Mok","year":"2017","unstructured":"Mok CC (2017) Calcineurin inhibitors in systemic lupus erythematosus. Best Pract Res Clin Rheumatol 31(3):429\u2013438. https:\/\/doi.org\/10.1016\/j.berh.2017.09.010","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"2642_CR23","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.jns.2016.08.057","volume":"369","author":"L Gotterer","year":"2016","unstructured":"Gotterer L, Li Y (2016) Maintenance immunosuppression in myasthenia gravis. J Neurol Sci 369:294\u2013302. https:\/\/doi.org\/10.1016\/j.jns.2016.08.057","journal-title":"J Neurol Sci"},{"issue":"11","key":"2642_CR24","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1007\/s40262-012-0007-8","volume":"51","author":"TK Bergmann","year":"2012","unstructured":"Bergmann TK, Barraclough KA, Lee KJ, Staatz CE (2012) Clinical pharmacokinetics and pharmacodynamics of prednisolone and prednisone in solid organ transplantation. Clin Pharmacokinet 51(11):711\u2013741. https:\/\/doi.org\/10.1007\/s40262-012-0007-8","journal-title":"Clin Pharmacokinet"},{"issue":"11","key":"2642_CR25","doi-asserted-by":"publisher","first-page":"7133","DOI":"10.1007\/s11033-014-3596-5","volume":"41","author":"D Bouzid","year":"2014","unstructured":"Bouzid D, Fourati H, Amouri A, Marques I, Abida O, Tahri N, Penha-Gon\u00e7alves C, Masmoudi H (2014) Autoimmune diseases association study with the KIAA1109-IL2-IL21 region in a Tunisian population. Mol Biol Rep 41(11):7133\u20137139. https:\/\/doi.org\/10.1007\/s11033-014-3596-5","journal-title":"Mol Biol Rep"},{"issue":"1","key":"2642_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.imlet.2008.03.002","volume":"118","author":"DA Chistiakov","year":"2008","unstructured":"Chistiakov DA, Voronova NV, Chistiakov PA (2008) The crucial role of IL-2\/IL-2RA-mediated immune regulation in the pathogenesis of type 1 diabetes, an evidence coming from genetic and animal model studies. Immunol Lett 118(1):1\u20135. https:\/\/doi.org\/10.1016\/j.imlet.2008.03.002","journal-title":"Immunol Lett"},{"issue":"11","key":"2642_CR27","doi-asserted-by":"publisher","first-page":"2494","DOI":"10.1111\/bcp.13367","volume":"83","author":"S Bremer","year":"2017","unstructured":"Bremer S, Vethe NT, Skauby M, Kasbo M, Johansson ED, Midtvedt K, Bergan S (2017) NFAT-regulated cytokine gene expression during tacrolimus therapy early after renal transplantation. Br J Clin Pharmacol 83(11):2494\u20132502. https:\/\/doi.org\/10.1111\/bcp.13367","journal-title":"Br J Clin Pharmacol"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-019-02642-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-019-02642-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-019-02642-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,11]],"date-time":"2022-09-11T14:06:49Z","timestamp":1662905209000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-019-02642-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,7]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["2642"],"URL":"https:\/\/doi.org\/10.1007\/s00228-019-02642-z","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,7]]},"assertion":[{"value":"23 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Ethics Committee of the Xiangya Hospital of Central South, and all patients provided written informed consent. The certificate number is 201703107.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}